ALX Oncology Holdings Inc. (ALXO) vs MediWound Ltd. (MDWD)

A side-by-side comparison of ALX Oncology Holdings Inc. and MediWound Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALXO vs MDWD

growth of $100 · dividends reinvested · last 6y
ALXO -96.0% (-41.4%/yr)MDWD -47.8% (-10.3%/yr)MDWD compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$4$52
ALXO MDWD

ALXO vs MDWD: by the numbers

  • •MDWD is the larger company ($170M vs $152M market cap).
  • •Both run net losses; ALXO's is the smaller (0.00% vs -170.10% net margin).

Metrics side by side

Valuation

MetricALXOMDWD
P/S ratioN/A14.32
P/B ratio1.124.77

Profitability

MetricALXOMDWD
Gross margin0.00%15.46%
Operating margin0.00%-149.06%
Net margin0.00%-170.10%
ROE-59.40%-56.61%
ROIC-56.53%-58.55%

Growth (annualized)

MetricALXOMDWD
Revenue CAGR (5Y)N/A-13.99%
Total return CAGR (5Y)-56.07%-9.04%

Frequently asked

How have ALXO and MDWD total returns compared?
Over the past 5 years, ALXO delivered -56.07% and MDWD delivered -9.04% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.